vimarsana.com

Page 2 - Cholangitis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ricky Safer: Working to Streamline Primary Sclerosing Cholangitis Diagnoses

The founder of PSC Partners Seeking a Cure discusses how screening and treatment for the rare disease has evolved since her diagnosis 20 years ago.

Ipsen, GENFIT Reveal Positive Phase III Trial Results Of Elafibranor In Patients With PBC

French pharmaceutical company Ipsen SA (IPSEY) and late-stage biopharmaceutical company GENFIT SA (GNFT) announced Friday positive topline data from the pivotal ELATIVE Phase III trial of elafibranor in patients with primary biliary cholangitis or PBC, a rare cholestatic liver disease.

Ipsen and GENFIT Enter Into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-Term Global Partnership

Agreement gives Ipsen global rights to develop and commercialize GENFIT's late-stage, first-in-class PPAR alpha and delta agonist elafibranor in Primary Biliary Cholangitis (PBC) Investigational

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.